ReviewPreventive medicine2011
Genital HPV infection and related lesions in men.
Review in Preventive medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.
- Global Type-Specific Genital Human Papillomavirus Prevalence in Men, by Sexual Orientation: A Systematic Review and Meta-Analysis.The Journal of infectious diseases · 2023Pooled it
- Detection of human papillomavirus in male genital samples.World journal of urology · 2025Observational
- Human Papilloma Virus Infection in Men: A Specific Human Virome or a Specific Pathology?Genes · 2025Article
- HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.Pathogens (Basel, Switzerland) · 2024Review
- The role of HR-HPV integration in the progression of premalignant lesions into different cancer types.Heliyon · 2024Review
- Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review.Viruses · 2024Review
- Review
- Proteases and HPV-Induced Carcinogenesis.Cancers · 2022Review
- Virus-Driven Carcinogenesis.Cancers · 2021Review
- Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations.Scientific reports · 2021Article
- The Prevalence and Genotype Distribution of Human Papillomaviruses Among Men in Henan Province of China.Frontiers in medicine · 2021Article
- Computational modeling of human papillomavirus with impulsive vaccination.Nonlinear dynamics · 2021Article
- Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42.BMC infectious diseases · 2019Article
- Review
- [Prophylactic vaccination against HP viruses for the prevention of cervical cancer : Implementation of gender neutral, prophylactic vaccination in Germany as an effective instrument for prevention].Der Urologe. Ausg. A · 2018Article
- Paediatric Virology and its interaction between basic science and clinical practice (Review).International journal of molecular medicine · 2018Review
- Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.Urologic oncology · 2018Article
- On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society.Israel journal of health policy research · 2017Article
- Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.International journal of cancer · 2017Article
- Including males in Canadian human papillomavirus vaccination programs: a policy analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Human papillomavirus (HPV) is highly prevalent in men and there is an interest in further understanding the relationship between HPV infection and disease in men, including the development of genital warts, penile intraepithelial neoplasia and invasive penile carcinomas. Genital warts are caused by HPV 6/11 and are the most common clinical manifestation of HPV in men. Though they are benign and not associated with mortality, they are a source of psychosocial distress and physical discomfort. HPV infection can also develop into invasive penile carcinoma which is associated with morbidity and mortality. Approximately 40% of invasive penile carcinomas are attributable to HPV with HPV 16, 18, and 6/11 being the genotypes most commonly detected in penile tumors. Penile carcinomas of the basaloid and warty histologic subtypes are most likely to test positive for HPV. In addition to HPV infection, the risk factors most strongly associated with penile cancer are lack of neonatal circumcision, phimosis (the inability of uncircumcised men to fully retract the foreskin), and anogenital warts. Male vaccination with the quadrivalent HPV vaccine that protects against HPV 6/11/16/18 has been shown to significantly reduce HPV-associated anogenital infection and disease in men. If the quadrivalent vaccine is successfully disseminated to large segments of the young male population, there is the potential for substantial reduction in genital HPV infection and related lesions in men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.